Mednet Logo
HomeQuestion

How would you approach dose modifications and/or frequency of lenalidomide in patients with advanced renal impairment (eGFR <30)?

2 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Chicago

Great question - comes up a lot in discussion with community providers.

The dosing is dependent on what your target dose would be.

If normal dosing was 25 mg and CrCl <30 and not on dialysis, then I follow the package insert "15 mg every other day". If the patient tolerates that ok, I increase to 10...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Winship Cancer Institute of Emory University

The "correct" dose for lenalidomide is a challenge. We know that renal function is a HUGE determinant of lenalidomide exposure (Chen et al., PMID 27351179 & Bridoux et al., PMID 27286995 & Guglieri-López et al., PMID 28039509), but it's NOT the only factor.

We should not forget that the right dose f...

Register or Sign In to see full answer

How would you approach dose modifications and/or frequency of lenalidomide in patients with advanced renal impairment (eGFR <30)? | Mednet